These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32273127)

  • 21. Open clinical uro-oncology trials in Canada.
    Mackenzie MJ; Rodrigues G; Winquist E
    Can J Urol; 2009 Jun; 16(3):4706-11. PubMed ID: 19497189
    [No Abstract]   [Full Text] [Related]  

  • 22. Open clinical uro-oncology trials in Canada.
    Rodrigues G; Winquist E
    Can J Urol; 2010 Dec; 17(6):5494-9. PubMed ID: 21172119
    [No Abstract]   [Full Text] [Related]  

  • 23. Open clinical uro-oncology trials in Canada.
    Rodrigues G; Winquist E
    Can J Urol; 2011 Jun; 18(3):5751-6. PubMed ID: 21703055
    [No Abstract]   [Full Text] [Related]  

  • 24. [New therapies for urologic cancer diseases. The Danish Society of Urology].
    Lund L; Borre M; Hermann GG; Svolgaard N;
    Ugeskr Laeger; 2008 Mar; 170(12):1057. PubMed ID: 18397675
    [No Abstract]   [Full Text] [Related]  

  • 25. Some observations on the pathology and natural history of urothelial neoplasms.
    Schade RO
    Beitr Pathol; 1972; 145(4):325-35. PubMed ID: 5021581
    [No Abstract]   [Full Text] [Related]  

  • 26. Prostatic and bladder cancer in the elderly.
    Gaddipati J; Ahmed T; Friedland M
    Clin Geriatr Med; 1987 Nov; 3(4):649-67. PubMed ID: 3315161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open clinical uro-oncology trials in Canada.
    Winquist E; Rodrigues G
    Can J Urol; 2011 Aug; 18(4):5849-55. PubMed ID: 21854720
    [No Abstract]   [Full Text] [Related]  

  • 28. [Update on the medical treatment of urologic tumors].
    Culine S
    Bull Cancer; 2000 Jan; 87(1):71-5. PubMed ID: 10673634
    [No Abstract]   [Full Text] [Related]  

  • 29. [Medical therapy of tumors. III].
    Cerimele E
    Clin Ter; 1980 Jul; 94(2):185-228. PubMed ID: 7004760
    [No Abstract]   [Full Text] [Related]  

  • 30. Non-extirpative treatment of myosarcomas of the bladder and prostate.
    Mackenzie AR; Sharma TC; Whitmore WF; Melamed MR
    Cancer; 1971 Aug; 28(2):329-34. PubMed ID: 5566356
    [No Abstract]   [Full Text] [Related]  

  • 31. Open clinical uro-oncology trials in Canada.
    Mackenzie M; Rodrigues G; Winquist E
    Can J Urol; 2007 Aug; 14(4):3662-7. PubMed ID: 17784993
    [No Abstract]   [Full Text] [Related]  

  • 32. Bladder cancer. Clinical guidelines in oncology.
    Montie JE; Abrahams NA; Bahnson RR; Eisenberger MA; El-Galley R; Herr HW; Hudes GR; Kuzel TM; Lange PH; Patterson A; Pollack A; Richie JP; Sexton WJ; Shipley WU; Small EJ; Trump DL; Walther PJ; Wilson TG;
    J Natl Compr Canc Netw; 2006 Nov; 4(10):984-1014. PubMed ID: 17112448
    [No Abstract]   [Full Text] [Related]  

  • 33. Trends in palliative care interventions among patients with advanced bladder, prostate, or kidney cancer: A retrospective cohort study.
    Lec PM; Lenis AT; Brisbane W; Sharma V; Golla V; Gollapudi K; Blumberg J; Drakaki A; Bergman J; Chamie K
    Urol Oncol; 2020 Nov; 38(11):854.e1-854.e9. PubMed ID: 32430252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostatic urethral recurrence of urachal adenocarcinoma.
    Ching CB; Chen L; Fergany A
    J Clin Oncol; 2011 Oct; 29(28):e736-8. PubMed ID: 21900110
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of Gender on Chemotherapeutic Response and Oncologic Outcomes in Patients Treated With Radical Cystectomy and Perioperative Chemotherapy for Bladder Cancer: A Systematic Review and Meta-Analysis.
    Kimura S; Iwata T; Abufaraj M; Janisch F; D'Andrea D; Moschini M; Al-Rawashdeh B; Fajkovic H; Seebacher V; Egawa S; Shariat SF
    Clin Genitourin Cancer; 2020 Apr; 18(2):78-87. PubMed ID: 31889669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarker classification, validation, and what to look for in 2017 and beyond.
    Davis JW
    BJU Int; 2017 May; 119(5):812-814. PubMed ID: 28117555
    [No Abstract]   [Full Text] [Related]  

  • 37. [An 18-year follow-up of a patient with four asynchronous malignant tumors of the urogenital system].
    Alferov SM; Grishin MA; Odintsov SV; Chuprik-Malinovskaia TP
    Urologiia; 2014; (1):68-72. PubMed ID: 24772778
    [No Abstract]   [Full Text] [Related]  

  • 38. Positive margins in urological oncology.
    Koch MO
    J Urol; 2007 Dec; 178(6):2249. PubMed ID: 17936808
    [No Abstract]   [Full Text] [Related]  

  • 39. Application of artificial intelligence to the management of urological cancer.
    Abbod MF; Catto JW; Linkens DA; Hamdy FC
    J Urol; 2007 Oct; 178(4 Pt 1):1150-6. PubMed ID: 17698099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reply by author.
    J Urol; 2015 May; 193(5):1613-4. PubMed ID: 25639762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.